KG-135, enriched with selected ginsenosides, inhibits the proliferation of human prostate cancer cells in culture and inhibits xenograft growth in athymic mice
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference53 articles.
1. The potent protective effect of wild ginseng (Panax ginseng C.A. Meyer) against benzo[alpha]pyrene-induced toxicity through metabolic regulation of CYP1A1 and GSTs;Gum;J. Ethnopharmacol.,2007
2. Antioxidant and anti-tumor promoting activities of the methanol extract of heat-processed ginseng;Keum;Cancer Lett.,2000
3. Effects of wild ginseng (Panax ginseng C.A. Meyer) leaves on lipid peroxidation levels and antioxidant enzyme activities in streptozotocin diabetic rats;Jung;Ethnopharmacol,2005
4. Molecular mechanisms underlying anti-tumor promoting activities of heat-processed Panax ginseng C.A. Meyer;Surh;J. Korean Med. Sci.,2001
5. Apoptotic effects of ginsenoside Rh2 on human malignant melanoma A375-S2 cells;Fei;Acta Pharmacol. Sin.,2002
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Pharmacokinetics and pharmacodynamics of Rh2 and aPPD ginsenosides in prostate cancer: a drug interaction perspective;Cancer Chemotherapy and Pharmacology;2023-09-15
2. Immunomodulatory, Anti-Inflammatory, and Anti-Cancer Properties of Ginseng: A Pharmacological Update;Molecules;2023-05-03
3. Nanodeliovery based Chinese medicine's bioactive compounds for treatment of respiratory disorders;Pharmacological Research - Modern Chinese Medicine;2022-12
4. Anti-tumor activities of Panax quinquefolius saponins and potential biomarkers in prostate cancer;Journal of Ginseng Research;2021-03
5. α2A-Adrenergic Receptor Inhibits the Progression of Cervical Cancer Through Blocking PI3K/AKT/mTOR Pathway;OncoTargets and Therapy;2020-10
α2A-Adrenergic Receptor Inhibits the Progression of Cervical Cancer Through Blocking PI3K/AKT/mTOR Pathway
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3